Naviswiss secures FDA 510k clearance for Naviplan, an advanced planning solution for hip replacement surgery
On October 21, 2021, Naviswiss, a Swiss-based medical technology company, received approval from the FDA to commercialise Naviplan in the United States. Naviplan is a digital pre-operative planning application allowing orthopaedic surgeons to conduct navigated CT-based total hip replacement surgery. It has the prospective to improve accuracy, predictability and provide seamless documentation of the outcome.
Jan Stifter, Naviswiss CEO, said that Naviplan and CT-based Navigation are a vital addition to the Naviswiss portfolio and complete their proffe...